NCT00869128View on ClinicalTrials.gov

A Study of the Efficacy of Prolonged-Release Melatonin Versus Placebo in Diabetic Patients Suffering From Insomnia

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 1995

Primary Completion Date

March 31, 1997

Study Completion Date

March 31, 1997

Conditions
Diabetes Mellitus, Type 2Insomnia
Interventions
DRUG

Circadin

2 mg prolonged-release melatonin

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Neurim Pharmaceuticals Ltd.

INDUSTRY

NCT00869128 - A Study of the Efficacy of Prolonged-Release Melatonin Versus Placebo in Diabetic Patients Suffering From Insomnia | Biotech Hunter | Biotech Hunter